Institution
First Affiliated Hospital of Guangzhou Medical University
Also known as: 广州医科大学附属第一医院
- 144running trials
- 58closed trials
- 1researcher
- 14,774publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo
Not yet recruiting
Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
Not yet recruiting
Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
Recruiting
Recruiting
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
Recruiting
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Enrolling by invitation
Recruiting
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
Recruiting
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
Showing 50 of 144.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer42 recruiting
- Bronchiectasis9 recruiting
- COPD9 recruiting
- Prostate cancer9 recruiting
- Asthma7 recruiting
- Cystic fibrosis4 recruiting
- Idiopathic pulmonary fibrosis4 recruiting
- Bladder cancer2 recruiting
- Chronic kidney disease2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- High blood pressure2 recruiting
- Obstructive sleep apnoea2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Acute myeloid leukaemia1 recruiting
- Alopecia areata1 recruiting
- Aortic aneurysm1 recruiting
- Brain metastases1 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diabetic eye disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- IgA nephropathy1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Pancreatic cancer1 recruiting
- Parkinson disease1 recruiting
- Tuberculosis1 recruiting
- Type 1 diabetes1 recruiting
- Ulcerative colitis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Robot-Assisted Versus Manual Puncture for Pulmonary Nodule Ablation
Completed
Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients
Completed
Recruiting
Completed
Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels
Completed
Terminated
Completed
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Completed
Completed
Completed
A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects
Completed
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System
Completed
Completed
Completed
Completed
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Completed
A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis
Completed
Completed
Completed
Efficacy and Safety of PFO Closure vs Medical Therapy in Alleviating Migraine
Completed
Terminated
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Completed
Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
Completed
Completed
Completed
Completed
Completed
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
Completed
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Terminated
Completed
Completed
Completed
The Effect of Sea Buckthorn Extract in Patients With Type 1 Diabetes
Completed
Completed
Showing 50 of 58.
Registry name variants (33)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120
155 trials
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120
15 trials
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong
2 trials
Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong 510120
2 trials
The First Affiliated Hospital of Guangzhou Medical University - Yanjiang Campus
Guangzhou, Guangdong 510120
2 trials
Contact: US Biogen Clinical Trial Center
NCT04921384Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou
1 trial
Contact: Jianxing He, MD
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong 510120
1 trial
Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong 510120
1 trial
Guangzhou Medical University First Affiliated Hospital
Guangzhou, Guangdong 510120
1 trial
NCT07622186A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Contact: Chengzhi Zhou (principal investigator)
The first affiliated hospital of Guangzhou medical university
Guanzhou, Guangdong 510120
1 trial
NCT07367529A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Contact: Wenhua Liang, Doctor
The First Affiliated Hospital of Guangzhou Medical University, Datansha Campus
Guangzhou, Guangdong 510163
1 trial
NCT07790822Cross-Regional Unmanned Aircraft Transport of Donor Lungs
Contact: Jiaqin Zhang
The First Affiliated Hospital of Guangzhou Medical University, Department of Pulmonary Oncology
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong
Guangzhou
1 trial
NCT07413952Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
Contact: Jiexia Zhang, Prof.
the First Affiliated Hospital of Guangzhou Medical University, Guangzhou,Guangdong 510120
Guangzhou, Guangdong
1 trial
NCT07588737Multimodal AI-Guided Recovery Management After Lung Cancer Surgery
Contact: Jianxing He
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163
Guangzhou, Guangdong 510100
1 trial
The First Affiliated Hospital of Guangzhou Medical University / Guangzhou Institute of Respiratory Health (National Clinical Research Center for Respiratory Disease)
Guangzhou, Guangdong 510120
1 trial
NCT07917078Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features
Contact: Nuofu Zhang, Prof.
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong 510163
1 trial
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong 510163
1 trial
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong 510163
1 trial
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong 510163
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 0224)
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 0403)
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 0412)
Guangzhou, Guangdong 510230
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
The First Affiliated Hospital of Guangzhou Medical University (Site 0749)
Guangzhou, Guangdong 510230
1 trial
The first affiliated hospital of Guangzhou medical university (Site 1637)
Guangzhou, Guangdong 510000
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 1777)
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 2211)
Guangzhou, Guangdong 510145
1 trial
Contact: Study Coordinator
The First Affiliated Hospital of Guangzhou Medical University (Site 2417)
Guangzhou, Guangdong 510160
1 trial
The First Affiliated Hospital Of Guangzhou Medical University - Site #28
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 3108)
Guangzhou, Guangdong 510160
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 3134)
Guangzhou, Guangdong 510140
1 trial
The First Affiliated Hospital of Guangzhou Medical University (Site 6036)
Guangzhou, Guangdong 510120
1 trial
The First Affiliated Hospital Of Guangzhou Medical University - Yanjiang W Road
Guangzhou, Guangdong 510120
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer189 works · 77 trials
- COPD118 works · 19 trials
- Asthma98 works · 12 trials
- Idiopathic pulmonary fibrosis29 works · 10 trials
- Bronchiectasis19 works · 11 trials
- Pulmonary arterial hypertension16 works · 5 trials
Institution data: ROR 00z0j0d77 (CC0-1.0)Updated 15 Nov 2026